Skip to main content
NanoRepro AG logo

NanoRepro AG — Investor Relations & Filings

Ticker · NN6 ISIN · DE0006577109 LEI · 3912008FCA63AGIMEV74 F Manufacturing
Open in API
Filings indexed 415 across all filing types
Latest filing 2015-05-29 Earnings Release
Country DE Germany
Listing F NN6

About NanoRepro AG

https://www.nanorepro.com/en/

NanoRepro AG is a company specializing in the development, manufacturing, and distribution of CE-marked rapid diagnostic tests (self-tests) and food supplements. The products are designed for both home and professional use. The company's portfolio covers various health areas, including family planning, preventive healthcare, disease detection, food intolerances, allergies, and infectious diseases. The primary goal is to provide accuracy in self-diagnostics for rapid disease detection and health monitoring.

Recent filings

Filing Released Lang Actions
NanoRepro AG: NanoRepro AG gibt Finanzergebnis des Geschaftsjahres 2014 bekannt
Earnings Release Classification · 99% confidence The document is a press release dated May 29, 2015, titled "NanoRepro AG gibt Finanzergebnis des Geschäftsjahres 2014 bekannt" (NanoRepro AG announces financial results for the fiscal year 2014). It explicitly details the financial figures for the past fiscal year (Jahresfehlbetrag, Umsatz) and provides an outlook for 2015. This content structure—announcing period results via a press release—is characteristic of an Earnings Release (ER). Although it contains annual results, the format is a brief announcement (under 5,000 characters) rather than the comprehensive 10-K filing itself, and it is explicitly labeled as a 'Pressemitteilung' (Press Release) distributed via DGAP, fitting the definition of an initial announcement of periodical financial results. FY 2014
2015-05-29 German
Jahresabschluss 2014
Annual Report Classification · 95% confidence The document contains a detailed balance sheet (Bilanz) and profit and loss statement (Gewinn- und Verlustrechnung) for the fiscal year ending December 31, 2014, including an asset schedule (Anlagenspiegel). This constitutes a comprehensive financial report for a full fiscal year. In the context of German corporate reporting, this is the primary component of an Annual Report (Jahresabschluss). FY 2014
2015-05-29 German
NanoRepro AG: NanoRepro AG schliet Kapitalerhohung erfolgreich ab
Share Issue/Capital Change Classification · 99% confidence The document text is a press release titled 'NanoRepro AG schließt Kapitalerhöhung erfolgreich ab' (NanoRepro AG successfully completes capital increase). It details the terms of a capital increase, the subscription ratio, the issue price, the total gross proceeds (around 1.5 million Euro), and the intended use of the funds (sales expansion, product portfolio development). This content directly relates to fundraising, financing activities, and changes in capital structure. This aligns perfectly with the definition for Capital/Financing Update (CAP). It is not an Annual Report (10-K), an Earnings Release (ER), or a simple announcement of a report (RPA/RNS), as it contains the substantive details of the financing event itself.
2015-03-25 German
NanoRepro AG: NanoRepro AG erweitert Produktportfolio im Business-to-Business-Bereich durch Einfuhrung neuer Schnelltests
Regulatory Filings Classification · 100% confidence The document is titled 'Pressemitteilung' (Press Release) and announces the expansion of NanoRepro AG's product portfolio by introducing five new rapid tests for professional medical use. It details product features, market strategy (B2B, international expansion), and mentions CE certification. The structure, tone, and content strongly indicate a news announcement regarding business operations and product development, rather than a formal regulatory filing like a 10-K, an earnings release (ER) which focuses on financial figures, or a specific legal/governance document. Since it is a general business update/product launch announcement, it fits best under the general 'Regulatory Filings' (RNS) category as a miscellaneous corporate news item, although 'ER' might be considered if it contained financial results, which it does not. Given the options, RNS serves as the best fit for a general corporate news release that isn't covered by a more specific code like DIV, CAP, or ER.
2015-03-10 German
NanoRepro AG: NanoRepro AG gibt den Start der Bezugsfrist ihrer Barkapitalerhohung bekannt
Share Issue/Capital Change Classification · 99% confidence The document is a press release from NanoRepro AG announcing the start of the subscription period for a cash capital increase ('Barkapitalerhöhung'). It details the terms of the share issuance, the subscription ratio, the use of proceeds, and mentions that the securities prospectus was approved by BaFin and will be published. This content directly relates to fundraising, financing activities, and changes in capital structure. Therefore, the most appropriate classification is 'Capital/Financing Update' (CAP).
2015-03-04 German
NanoRepro AG: NanoRepro AG starkt Prasenz in Deutschland durch Kauf der Marke alphabiol
M&A Activity Classification · 99% confidence The document is a press release dated March 4, 2015, announcing that NanoRepro AG has acquired the brand 'alphabiol' to expand its product portfolio with nutritional supplements. It details the strategic rationale and expected contribution to the German business starting in FY 2015. This type of announcement, detailing a corporate transaction (acquisition/merger) that is not a formal regulatory filing like a 10-K or a specific financial report, falls best under the category of M&A Activity (TAR) or potentially a general Regulatory Filing (RNS) if TAR is too specific for a small acquisition announcement. However, since it explicitly details a takeover/acquisition of a brand/assets, TAR (Merger & Acquisition Activity) is the most appropriate fit among the provided options, as it describes a significant corporate transaction.
2015-03-04 German

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.